瘤学试验中的手术质量:患者的观点
J W Butterworth1, P R Boshier1, A Tsai1
1Department of Surgery and Cancer, Imperial College London, UK.
概括
患者强调试验中手术质量的关键挑战,例如床位不足和资金不足. 他们提出的战略,包括监测操作标准和培训非专业人员,可以提高瘤学试验的质量.
科学领域:
- 在瘤学瘤学.
- 手术试验的试验
- 以患者为中心的护理
背景情况:
- 越来越强调患者参与医疗保健研究决策.
- 关于瘤学试验中的手术质量的专家意见存在,但患者的观点未得到充分研究.
研究的目的:
- 在瘤临床试验中探索患者对手术质量的看法.
- 确定患者感知到的挑战和建议的缓解策略.
主要方法:
- 两个重点小组,包括来自食道患者协会 (OPA) 的十名参与者.
- 一项由41名OPA成员完成的半结构化调查,基于焦点小组主题.
主要成果:
- 确定了45个主题:手术质量 (16),挑战 (16) 和策略 (13).
- 主要挑战:床位不足 (90%) 和资金缺乏 (75%).
- 主要策略:监测操作标准 (94%) 和培训术后并发症 (94%).
结论:
- 这项研究是首次调查患者对试验中的手术质量的看法.
- 医疗保健规划人员和外科瘤专业人员应整合患者识别的挑战和策略,以提高临床试验中的外科质量.
相关概念视频
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Nursing Ethical Principles II
2.1K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.1K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

